GABPA |
A549 (lung carcinoma) |
1 h with 0.02% Ethanol (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BPY
|
MA0062.3
|
GABPA |
CUTLL1 (T-cell lymphoblastic lymphoma 1) |
vehicle |
Permissive
Robust
|
Homo sapiens |
GSE51800
...
|
MA0062.3
|
GABPA |
bone marrow-derived macrophages |
No treatment |
Permissive
Robust
|
Mus musculus |
GSE88699
...
|
MA0062.3
|
GABPA |
bone marrow-derived macrophages |
No treatment |
Permissive
Robust
|
Mus musculus |
GSE88699
...
|
MA0062.3
|
GABPA |
bone marrow-derived macrophages |
alpha amanitin 10μg/ml for 5 hours (SIGMA) |
Permissive
Robust
|
Mus musculus |
GSE88699
...
|
MA0062.3
|
GABPA |
THP-1 (acute monocytic leukemia) |
Treatment: 100 nM ethanol for 24 hrs |
Permissive
Robust
|
Homo sapiens |
GSE98093
...
|
MA0062.3
|
GABPA |
THP-1 (acute monocytic leukemia) |
Treatment: 100 nM 1,25(OH)2D3 for 24 hrs |
Permissive
|
Homo sapiens |
GSE98093
...
|
MA0062.3
|
GABPA |
EML -C1(EML, clone 1) |
Strain: B6D2F1 Genotype: CD34 negative |
Permissive
|
Mus musculus |
GSE100689
...
|
MA0062.3
|
GABPA |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BGC
|
MA0062.3
|
GABPA |
HeLa S3 (cervical adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BHS
|
MA0062.3
|
GABPA |
WA01 (H1, human embryonic stem cells) |
|
Permissive
|
Homo sapiens |
ENCSR000BIW
|
MA0062.3
|
GABPA |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BJK
|
MA0062.3
|
GABPA |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BLO
|
MA0062.3
|
GABPA |
SK-N-SH (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BTG
|
MA0062.3
|
GABPA |
HL-60 (acute myeloid leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BTK
|
MA0062.3
|
GABPA |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BUK
|
MA0062.3
|
GABPA |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR038RXU
|
MA0062.3
|
GABPA |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR290MUH
|
MA0062.3
|
GABPA |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR331HPA
|
MA0062.3
|
GABPA |
CD34+CD133+ hematopoietic progenitors |
|
Permissive
Robust
|
Homo sapiens |
GSE24933
...
|
MA0062.3
|
GABPA |
MEL cell line |
|
Permissive
|
Mus musculus |
ENCSR000ESK
...
|
MA0062.3
|
GABPA |
CH12.LX (Mouse lymphoma) |
|
Permissive
Robust
|
Mus musculus |
ENCSR000EQS
...
|
MA0062.3
|
GABPA |
CD4+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE101936
...
|
MA0062.3
|
GABPA |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR350ORK
|
MA0062.3
|
GABPA |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR269TNX
|
MA0062.3
|
GABPA |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE53366
...
|
MA0062.3
|
GABPA |
RWPE1 (prostate epithelial cells) |
|
Permissive
|
Homo sapiens |
GSE29808
|
MA0062.3
|
GABPA |
HeLa (cervical adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE31417
|
MA0062.3
|
GABPA |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE49091
|
MA0062.3
|
GABPA |
DU145 (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE59021
|
MA0062.3
|
GABPA |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72082
|
MA0062.3
|
GABPA |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE72082
|
MA0062.3
|
GABPA |
VCaP (prostate carcinoma) |
ETOH |
Permissive
Robust
|
Homo sapiens |
GSE49091
|
MA0062.3
|
GABPA |
VCaP (prostate carcinoma) |
R1881 |
Permissive
Robust
|
Homo sapiens |
GSE49091
|
MA0062.3
|
GABPA |
VCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE49091
|
MA0062.3
|